Right Aid Globals

Myhep Lvir Tablet is a medicine that contains the active substances ledipasvir and sofosbuvir. It is indicated to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C is a virus that mainly infects the liver. It is mainly triggered by a virus named Flavivirus. Most patients remain asymptomatic, and the symptoms show up only when they develop chronic liver disease or cirrhosis. The progression of liver disease is faster in people who consume alcohol and those with a weak immune system. The main treatment goal for Hepatitis C infection is complete eradication of the virus causing this infection.

This drug is contraindicated for individuals with decompensated cirrhosis or severe liver disease. In such cases, alternative treatment options should be considered. This drug should not be used if you have any known allergy or hypersensitivity to Myhep Lvir Tablet or other ingredients in the medication. Your liver function may change with the treatment of hepatitis C and, therefore, affect other medications (e.g., medicines used to suppress your immune system, etc.). Your doctor may need to monitor your other medicines and make dose adjustments closely. If you have liver disease other than hepatitis C, are awaiting a liver transplant, have a current or previous infection with the hepatitis B virus (HBV), or receive ongoing treatment for HIV infection. It's important to inform your doctor. They will consider these conditions before starting treatment.

Talk to your doctor immediately before taking this drug if you have diabetes. You may need closer monitoring of your blood glucose levels or adjustment of your diabetes medication after starting this drug. Some diabetic patients have experienced low sugar levels in the blood (hypoglycemia) after starting treatment with medicines like Myhep Lvir Tablet. The doctor will test your blood before, during, and after your treatment with this medicine. So that your doctor can confirm that your treatment has worked and you are free of the hepatitis C virus, do not breastfeed during treatment with this tablet. It is unknown whether this drug passes into human breast milk. Consult your doctor if you are breastfeeding. Do not give this tablet to children under three years of age. The use of this drug has not yet been studied. This tablet can interact with certain medications, potentially affecting their efficacy or increasing the risk of side effects. It's necessary to inform your doctor about all your medications, including prescription, over-the-counter, and herbal supplements, to ensure no potential interactions.

• Chronic Hepatitis C virus infection.

• Lamivudine indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children and also used in the treatment of Hepatitis B virus infection.

• Lamivudine belongs to a class of medication called nucleoside reverse transcriptase inhibitors. It decreases the amount of virus (HIV and hepatitis) in the blood. It also increases the number of infection fighting cells in the body (CD4 cells). It does not cure HIV completely but reduces the chances of getting acquired immunodeficiency syndrome (AIDS) and HIV related infections or cancer.

• runny nose; rash or hair loss; fever; insomnia ., indigestion, nausea, diarrhea; cough, dizzy or tired; rash, joint pain, itching; hair loss; headache, stomach pain, muscle pain or discomfort; vomiting, Feeling weak

• Stavudine is used in combination with other anti-viral drugs in the treatment of Human Immunodeficiency Virus (HIV) infection. It does not cure the infection, but prevents the spread of HIV and HIV-related illnesses such as suppression of immunity, cancer and other infections.

• Stavudine belongs to a group of drugs called as nucleoside reverse transcriptase inhibitors (NRTIs). It works by inhibiting multiplication of viruses thus decreasing their levels in the infected patient.

• Fatigue, Nausea, abdominal pain, dyspepsia, insomnia, depression, somnolence, neuritis, abnormal dreams or thoughts, diarrhea, peripheral neuropathy, dizziness, skin rashes and pruritus ., paresthesia, headache.

Vonavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Vonavir is not a complete cure for HIV but may reduce chances of getting AIDS.

Vonavir belongs to a class of medication called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It prevents the HIV from multiplying in the blood and thus reducing chances of getting HIV related illnesses, including serious infections.

Tenofovir is used in combination with other antiviral drugs in the treatment of human immunodeficiency virus (HIV) infections. It may also be used in very limited cases of long-term infections of liver caused by hepatitis B virus.

• Ricovir EM 200 mg/300 mg Tablet is used in the treatment of HIV infection.

• Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ricovir EM 200 mg/300 mg Tablet is to be taken with food.

• Ricovir EM 200 mg/300 mg Tablet is a combination of two anti-HIV medicines: Emtricitabine and Tenofovir disoproxil fumarate. They prevent HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.

Myhep All tablet contains the active components Sofosbuvir and Velpatasvir.  It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Myhep All tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.

If you have a known allergy or hypersensitivity to Myhep All tablet or any of the components of the medication, you should not take it. The safety and efficacy of sofosbuvir and velpatasvir combination therapy have not been established in children under 18. Its use in the pediatric population is currently limited. It is recommended to use alternative treatment options or adjust the dosage in these cases. 

• To treat chronic hepatitis C (HCV) infection.

Myhep Dvir Tablet contains active agents Daclatasvir and Sofosbuvir. It is an antiviral medication used to treat chronic hepatitis C virus (HCV) infections. Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV). Talk to your doctor if you have liver problems other than hepatitis C infection, had a liver transplant, diabetes, heart disorders, severe kidney problems, or are on dialysis before taking Myhep Dvir Tablet. Your physician will perform blood tests to check for hepatitis B virus infection before starting treatment with this medicine, as this medicine can reactivate the hepatitis B virus. 

Hepatitis B virus reactivation can cause serious liver problems and liver failure. It is vital to inform your doctor if you are taking or have taken any medication for heart problems in the past months. Elderly patients may be more susceptible to the side effects of Myhep Dvir Tablet and may require lower doses or closer monitoring during treatment. The safety and effectiveness of pediatric patients have not been established. These medications should only be used in children under the guidance of a pediatric specialist.

• Treatment of chronic hepatitis C virus (HCV) infection

Trustiva Tablet is a combination of antiretrovirals medicines. It is prescribed to treat HIV (human immunodeficiency virus) infection. It boosts up the immunity to fight against HIV to manage or treat AIDS (acquired immunodeficiency syndrome).

• many of the highly active antiretroviral therapies (HAART) available for patients with HIV are effective at slowing the progression of the disease cased by HIV infection. Unfortunately, a cure still does not exist.